These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17665945)

  • 1. Nanoparticles incorporated in bilaminated films: a smart drug delivery system for oral formulations.
    Cui F; He C; Yin L; Qian F; He M; Tang C; Yin C
    Biomacromolecules; 2007 Sep; 8(9):2845-50. PubMed ID: 17665945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of chitosan-ethylenediaminetetraacetic acid hydrogel films for the mucoadhesive transbuccal delivery of insulin.
    Cui F; He C; He M; Tang C; Yin L; Qian F; Yin C
    J Biomed Mater Res A; 2009 Jun; 89(4):1063-71. PubMed ID: 18478558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
    Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
    Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery.
    Yin L; Ding J; He C; Cui L; Tang C; Yin C
    Biomaterials; 2009 Oct; 30(29):5691-700. PubMed ID: 19615735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodegradable in situ gelling system for subcutaneous administration of ellagic acid and ellagic acid loaded nanoparticles: evaluation of their antioxidant potential against cyclosporine induced nephrotoxicity in rats.
    Sharma G; Italia JL; Sonaje K; Tikoo K; Ravi Kumar MN
    J Control Release; 2007 Mar; 118(1):27-37. PubMed ID: 17258836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
    Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
    Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of chitosan-6-mercaptonicotinic acid nanoparticles for oral peptide drug delivery.
    Millotti G; Perera G; Vigl C; Pickl K; Sinner FM; Bernkop-Schnürch A
    Drug Deliv; 2011 Apr; 18(3):190-7. PubMed ID: 21039318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
    Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quaternized chitosan (QCS)/poly (aspartic acid) nanoparticles as a protein drug-delivery system.
    Wang Tw; Xu Q; Wu Y; Zeng Aj; Li M; Gao H
    Carbohydr Res; 2009 May; 344(7):908-14. PubMed ID: 19303066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan graft copolymer nanoparticles for oral protein drug delivery: preparation and characterization.
    Qian F; Cui F; Ding J; Tang C; Yin C
    Biomacromolecules; 2006 Oct; 7(10):2722-7. PubMed ID: 17025345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles.
    Jintapattanakit A; Junyaprasert VB; Mao S; Sitterberg J; Bakowsky U; Kissel T
    Int J Pharm; 2007 Sep; 342(1-2):240-9. PubMed ID: 17597316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.
    Sun L; Wang Y; Jiang T; Zheng X; Zhang J; Sun J; Sun C; Wang S
    ACS Appl Mater Interfaces; 2013 Jan; 5(1):103-13. PubMed ID: 23237208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
    Grenha A; Remuñán-López C; Carvalho EL; Seijo B
    Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiomer nanoparticles: stabilization via covalent cross-linking.
    Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
    Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and development of a mucoadhesive buccal film bearing progesterone.
    Jain SK; Jain A; Gupta Y; Kharya A
    Pharmazie; 2008 Feb; 63(2):129-35. PubMed ID: 18380399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder.
    Barthelmes J; Perera G; Hombach J; Dünnhaupt S; Bernkop-Schnürch A
    Int J Pharm; 2011 Sep; 416(1):339-45. PubMed ID: 21726619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.